Table 1.
Baseline participants’ characteristics by cardiovascular disease incidence and mortality status.
| Non-incident CVD (N=1474) |
Incident CVD (N=847) |
CVD death (N=316) |
|
|---|---|---|---|
| Age (years), median (IQR) | 53.1 (48.0, 60.0) | 57.3 (51.0, 64.4) | 58.4 (52.6, 66.2) |
| Sex, % Men | 60.0 | 58.3 | 56.8 |
| Smoking status, % | |||
| Former | 33.3 | 33.4 | 29.6 |
| Current | 32.3 | 36.4 | 34.3 |
| BMI, median (IQR) | 29.8 (26.3, 34.2) | 30.4 (27.1, 34.5) | 30.4 (27.1, 34.3) |
| LDL cholesterol (mg/dL), median (IQR) | 114 (92, 135) | 121 (99, 142) | 121 (100, 144) |
| HDL cholesterol (mg/dL), median (IQR) | 44 (38, 53) | 42 (36, 50) | 41 (36, 49) |
| Systolic blood pressure, median (IQR) | 122 (111, 135) | 129 (118, 141) | 133 (120, 144) |
| Hypertension, % | 15.3 | 30.1 | 34.5 |
| Diabetes, % | 40.3 | 61.9 | 69.2 |
| Albuminuria, % | |||
| Microalbuminuria | 15.1 | 24.5 | 24.2 |
| Macroalbuminuria | 6.4 | 15.8 | 24.4 |
| Urinary arsenic (μg/g creatinine)* | 10.2 (5.9, 16.7) | 10.3 (6.0, 17.3) | 11.2 (6.6, 18.2) |
CVD: Cardiovascular disease, IQR: interquartile range.
*
Urinary arsenic corresponds to the sum of inorganic and methylated species (methylarsonic acid and dimethylarsinic acid) in the urine.